Clade Therapeutics

Cambridge, United States

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

$87.0M raised

Nov 2021

Series A

Biotechnology Health Care Medical

Top Investors

Bristol-Myers Squibb Emerson Collective LifeSci Venture Partners Syncona Partners LLP

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Clade Therapeutics

How much funding has Clade Therapeutics raised?

Clade Therapeutics has raised $87.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Who are Clade Therapeutics's investors?

Clade Therapeutics's investors include Bristol-Myers Squibb, Emerson Collective, LifeSci Venture Partners, Syncona Partners LLP.

Where is Clade Therapeutics headquartered?

Clade Therapeutics is headquartered in Cambridge, United States.

What does Clade Therapeutics do?

Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.

What stage is Clade Therapeutics at?

Clade Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 3, 2021.

MLA

"Clade Therapeutics — Funding & Investors." VCBacked, November 3, 2021, https://www.vcbacked.co/company/clade-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Clade Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/clade-therapeutics

Wikipedia (cite web)

{{cite web |title=Clade Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/clade-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 3, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K